Skip to main content

Table 2 Maternal and fetal outcomes of study participants, ACSH and MGH, North Ethiopia 2016/17. Values are given as N, mean (SD)

From: Gestational hypertension and progression towards preeclampsia in Northern Ethiopia: prospective cohort study

Variables GH-GH
N=199
GH-PE
N=41
Total
N=240
P
Maternal outcomes
 Proteinuria - 13 (31.7%) 13 (5.4%) -
 Renal impairment - 5 (12.2%) 5 (2.1%) -
Neurologic Disease
 Headache - 20 (48.8%) 20 (8.3%) -
 Blurring of Vision - 5 (12.2%) 5 (2.1%) -
 Abnormal body movement - 1 (2.4%) 1 (0.4%) -
 Thrombocytopenia - 4 (9.8%) 4 (1.7%) -
Liver dysfunction
 Right upper quadrant pain - 12 (29.3 %) 12 (5.0%) -
 Epigastric pain - 6 (14.6%) 6 (2.5%) -
 Liver enzyme elevation - 7 (17.1%) 7 (2.9%) -
 Sever hypertension - 25 (61.0%) 25 (10.4%) -
 APH 4 (2.0%) 10 (24.4%) 14 (5.8%) 0.24
Mode of delivery
 Vaginal delivery 162 (81.4%) 29 (70.7%) 191 (79.6%) 0.58
 Instrumental delivery 4 (2.0%) - 4(1.7%) 0.36
 CS delivery 33 (16.6%) 12(29.3 %) 45 (18.8%) 0.81
Fetal outcomes
 Gestational at delivery in weeks 38.6(2.4) 38.0 (2.0) - 0.56
 Birth weight in grams 3167.0(1236.2) 2917.1 (545.4) - 0.29
 1st minute Apgar score >6 193 (97.0%) 40 (97.6%) 233 (97.1%) 0.98
 1st minute Apgar score 1-6 5 (2.5%) 1 (2.4%) 6 (2.5%) 0.98
 Admission to NICU 26 (13.1%) 5 (12.2%) 31 0.06
 Stillbirth 1 - 1 0.65
  1. APH antepartum hemorrhage, CS cesarean section, GH gestational hypertension, NICU neonatal intensive care unit, PE preeclampsia, P Pearson X2 test for categorical variables and two tailed student’s t test for continuous variables